145 related articles for article (PubMed ID: 2981613)
1. Anti-transferrin receptor antibody linked to Pseudomonas exotoxin as a model immunotoxin in human ovarian carcinoma cell lines.
Pirker R; FitzGerald DJ; Hamilton TC; Ozols RF; Willingham MC; Pastan I
Cancer Res; 1985 Feb; 45(2):751-7. PubMed ID: 2981613
[TBL] [Abstract][Full Text] [Related]
2. Characterization of immunotoxins active against ovarian cancer cell lines.
Pirker R; FitzGerald DJ; Hamilton TC; Ozols RF; Laird W; Frankel AE; Willingham MC; Pastan I
J Clin Invest; 1985 Sep; 76(3):1261-7. PubMed ID: 3930572
[TBL] [Abstract][Full Text] [Related]
3. Enhanced therapeutic efficacy against an ovarian tumor xenograft of immunotoxins used in conjunction with recombinant alpha-interferon.
Pearson JW; Hedrick E; Fogler WE; Bull RL; Ferris DK; Riggs CW; Wiltrout RH; Sivam G; Morgan AC; Groves E
Cancer Res; 1990 Oct; 50(19):6379-88. PubMed ID: 2144790
[TBL] [Abstract][Full Text] [Related]
4. Verapamil enhances the toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin and antitransferrin receptor with Pseudomonas exotoxin.
Akiyama S; Gottesman MM; Hanover JA; Fitzgerald DJ; Willingham MC; Pastan I
J Cell Physiol; 1984 Sep; 120(3):271-9. PubMed ID: 6086678
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of an immunotoxin made with Pseudomonas exotoxin in a nude mouse model of human ovarian cancer.
FitzGerald DJ; Willingham MC; Pastan I
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6627-30. PubMed ID: 3018739
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of the activity of immunotoxins by analogues of verapamil.
Pirker R; FitzGerald DJ; Raschack M; Frank Z; Willingham MC; Pastan I
Cancer Res; 1989 Sep; 49(17):4791-5. PubMed ID: 2788030
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of the activity of immunotoxins made with either ricin A chain or Pseudomonas exotoxin in human ovarian and epidermoid carcinoma cell lines.
Pirker R; FitzGerald DJ; Willingham MC; Pastan I
Cancer Res; 1988 Jul; 48(14):3919-23. PubMed ID: 3260128
[TBL] [Abstract][Full Text] [Related]
8. Single-chain immunotoxins directed at the human transferrin receptor containing Pseudomonas exotoxin A or diphtheria toxin: anti-TFR(Fv)-PE40 and DT388-anti-TFR(Fv).
Batra JK; Fitzgerald DJ; Chaudhary VK; Pastan I
Mol Cell Biol; 1991 Apr; 11(4):2200-5. PubMed ID: 2005905
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of intraperitoneal Pseudomonas exotoxin immunoconjugate OVB3-PE in patients with ovarian cancer.
Pai LH; Bookman MA; Ozols RF; Young RC; Smith JW; Longo DL; Gould B; Frankel A; McClay EF; Howell S
J Clin Oncol; 1991 Dec; 9(12):2095-103. PubMed ID: 1960550
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity in mice of an immunotoxin made with anti-transferrin receptor and a recombinant form of Pseudomonas exotoxin.
Batra JK; Jinno Y; Chaudhary VK; Kondo T; Willingham MC; FitzGerald DJ; Pastan I
Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8545-9. PubMed ID: 2510169
[TBL] [Abstract][Full Text] [Related]
11. Pseudomonas exotoxin coupled to a monoclonal antibody against ovarian cancer inhibits the growth of human ovarian cancer cells in a mouse model.
Willingham MC; FitzGerald DJ; Pastan I
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2474-8. PubMed ID: 3104916
[TBL] [Abstract][Full Text] [Related]
12. The effects of transferrin receptor antibody, transferrin receptor antibody bound to Pseudomonas exotoxin and transforming growth factor-alpha bound to Pseudomonas exotoxin on human tenon's capsule fibroblast proliferation.
Smyth RJ; Kitada S; Lee DA
J Ocul Pharmacol; 1992; 8(1):83-90. PubMed ID: 1402298
[TBL] [Abstract][Full Text] [Related]
13. Intraductal administration of transferrin receptor-targeted immunotoxin clears ductal carcinoma in situ in mouse models of breast cancer-a preclinical study.
Wang G; Kumar A; Ding W; Korangath P; Bera T; Wei J; Pai P; Gabrielson K; Pastan I; Sukumar S
Proc Natl Acad Sci U S A; 2022 Jun; 119(24):e2200200119. PubMed ID: 35675429
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas exotoxin-anti-TAC. Cell-specific immunotoxin active against cells expressing the human T cell growth factor receptor.
FitzGerald DJ; Waldmann TA; Willingham MC; Pastan I
J Clin Invest; 1984 Sep; 74(3):966-71. PubMed ID: 6432853
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor activity of K1-LysPE38QQR, an immunotoxin targeting mesothelin, a cell-surface antigen overexpressed in ovarian cancer and malignant mesothelioma.
Hassan R; Viner JL; Wang QC; Margulies I; Kreitman RJ; Pastan I
J Immunother; 2000; 23(4):473-9. PubMed ID: 10916757
[TBL] [Abstract][Full Text] [Related]
16. Monovalent immunotoxin containing truncated form of Pseudomonas exotoxin as potent antitumor agent.
Debinski W; Pastan I
Cancer Res; 1992 Oct; 52(19):5379-85. PubMed ID: 1394141
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effects of B3-PE and B3-LysPE40 in a nude mouse model of human breast cancer and the evaluation of B3-PE toxicity in monkeys.
Pai LH; Batra JK; FitzGerald DJ; Willingham MC; Pastan I
Cancer Res; 1992 Jun; 52(11):3189-93. PubMed ID: 1591729
[TBL] [Abstract][Full Text] [Related]
18. Antibody-Pseudomonas exotoxin A conjugates cytotoxic to human breast cancer cells in vitro.
Bjorn MJ; Groetsema G; Scalapino L
Cancer Res; 1986 Jul; 46(7):3262-7. PubMed ID: 3011243
[TBL] [Abstract][Full Text] [Related]
19. Enhanced therapeutic efficacy of an immunotoxin in combination with chemotherapy against an intraperitoneal human tumor xenograft in athymic mice.
Pearson JW; Sivam G; Manger R; Wiltrout RH; Morgan AC; Longo DL
Cancer Res; 1989 Sep; 49(18):4990-5. PubMed ID: 2504482
[TBL] [Abstract][Full Text] [Related]
20. The recombinant immunotoxin anti-Tac(Fv)-Pseudomonas exotoxin 40 is cytotoxic toward peripheral blood malignant cells from patients with adult T-cell leukemia.
Kreitman RJ; Chaudhary VK; Waldmann T; Willingham MC; FitzGerald DJ; Pastan I
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8291-5. PubMed ID: 2236041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
